Nutritional Advice El Mondo

Nutritional advice

Chronic diseases

Scientific studies (review articles) on the relationship between diet/nutrients and chronic diseases:
One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of randomized, placebo-controlled double blind clinical trials (RCTs) will answer the following question:
"Do taking dietary supplements make sense?" Yes for a positive conclusion and no for a negative conclusion.

One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of cohort studies or case-control studies will answer the following question:
"Should I change my diet?".

2023:

  1. High β-carotene dietary intake reduces Parkinson's disease among women
  2. 50g/d legume dietary intake may reduce mortality from all causes

2022:

  1. Selenium supplementation reduces postpartum depression
  2. Tomato intake causally reduces TNF-α levels in adults
  3. 400 mg/day vitamin C supplementation improves lung function of COPD patients
  4. Vitamin E supplements enhance quality of life of rheumatoid arthritis patients
  5. Meat intake may increase kidney stones
  6. High-dose dietary intake of vitamins A and B reduces glaucoma
  7. Higher intake of antioxidant-rich foods reduces Parkinson's disease

2021:

  1. 0.8-10 mg/d folic acid supplements decrease CRP levels
  2. Low vitamin D level increases asthma in children
  3. Low vitamin D level increases acne
  4. Selenium supplementation decreases hs-CRP level among patients with metabolic diseases
  5. NAC supplementation could improve lung function in patients with acute exacerbation of chronic obstructive pulmonary disease
  6. Vitamin B1 supplementation reduces ICU delirium in critically ill patients
  7. Soy supplementation improves insulin resistance for nonalcoholic fatty liver disease
  8. 540 mg/d green tea catechins supplementation reduces UV-induced damage due to erythema inflammation
  9. Cardiovascular reserve is improved after kidney-transplantation
  10. Vitamin B1 + vitamin C supplementation does not reduce mortality in patients with sepsis or septic shock
  11. Grape products containing polyphenols supplementation improves status of oxidative stress
  12. Vitamin B supplementation is effective in treating mouth ulcers
  13. L-carnitine supplementation should be supported in hemodialysis patients
  14. Carotenoid supplements decrease inflammation
  15. Coenzyme Q10 supplementation reduces oxidative stress
  16. 400 mg/day vitamin B2 supplementation decrease migraine attacks
  17. A higher manganese level increases MS
  18. Peripheral neuropathy is associated with lowered plasma vitamin B12 levels
  19. Resistant starch type 2 improves residual renal function of patients under maintenance hemodialysis
  20. Intravenous NAC administration decreases serum creatinine levels
  21. Probiotic, prebiotic and synbiotic supplementation improve oxidative stress in patients with chronic kidney disease
  22. Ginger supplementation improves oxidative stress levels
  23. Serum albumin concentrations are lower in patients with stable COPD
  24. Melatonin supplements have positive effects on sleep quality in adults with metabolic disorders

2020:

  1. 0.5 to 6 g/d taurine supplementation reduces total cholesterol and triglyceride in patients with liver dysregulation
  2. Patients with diabetic kidney disease benefit from <0.8 g protein per kilogram body weight per day
  3. <100 mg/day isoflavones reduce IL-6 and TNF-α levels
  4. 0.5 servings of fish per week reduce multiple sclerosis
  5. A higher dietary intake of fruit, dietary fiber, fish and vitamine C reduce COPD in adults
  6. Higher selenium and lower zinc level increase risk of vitiligo
  7. Higher serum levels of homocysteine increase multiple sclerosis
  8. Physical exercise offers benefits to patients with chronic kidney disease
  9. 300 mg/day dietary anthocyanins reduce inflammation
  10. Pomegranate decreases inflammation in adults
  11. LDL cholesterol-lowering treatment reduce risk of major vascular events
  12. Hepatitis B virus infection increases chronic kidney disease
  13. Lead increases ALS
  14. Meat is not a risk factor for asthma in children

2019:

  1. Vitamin B12, D and E reduce eczema
  2. Higher levels of selenium in cerebrospinal fluid increase Parkinson's disease
  3. Omega-3 supplementation decreases CRP levels in patients on hemodialysis
  4. Low selenium and zinc levels increase rheumatoid arthritis
  5. 60-500 mg/day coenzyme Q10 supplements reduce inflammation
  6. Egg consumption does not increase inflammation
  7. Hypomagnesemia increases all-cause mortality in end-stage renal disease patients
  8. Vitamin D improves fasting glucose among patients with chronic kidney disease
  9. Dietary DHA, DPA and EPA are associated with higher lung function among current smokers
  10. Exercise intervention in kidney transplant recipients improves quality of life
  11. 200g vegetables per day reduce gallstone disease
  12. ≥12 weeks of L-carnitine supplements reduce inflammation
  13. Plasma creatinine seems to be a promising prognostic biomarker for ALS
  14. 10-40 g/day dietary fiber intake reduce diverticular disease risk
  15. Higher hemoglobin levels decrease transfusion risk in predialysis patients with CKD
  16. Magnesium deficiency increases risk of ADHD
  17. High prenatal vitamin D level reduces risk autism-related traits later in life
  18. 3 cups/d coffee consumption reduce risk of all-cause mortality
  19. Dietary n-3 PUFAs reduce ulcerative colitis
  20. 15 minutes/week sunlight exposure decreases risk of Parkinson's disease

2018:

  1. Dairy products, high purine vegetables, soy foods and coffee decrease gout
  2. Postherpetic neuralgia patients benefit from vitamin B12 supplementation
  3. 320 to 1500 mg/day magnesium supplementation decreases CRP levels
  4. 1 g/day salt reduction reduces blood pressure in end-stage renal disease
  5. Coffee consumption is associated with a higher circulating level of adiponectin in women
  6. Higher intakes of fruit and vegetables improve immune function
  7. Oral supplementation with chondroitin sulfate reduces pain in knee osteoarthritis
  8. Coffee consumption is associated with a lower level of serum CRP in humans
  9. Milk increases acne
  10. 1 time/week fish consumption from 6-9 months reduces asthma and wheeze in children up to 4.5 years old
  11. A high uric acid level plays a protective role in ALS
  12. Coenzyme Q10 supplementation reduces serum triglycerides levels of patients with metabolic disorders
  13. Zinc deficiency increases risk of autoimmune disorders

2017:

  1. Cranberry may be effective in preventing urinary tract infection recurrence in women
  2. High consumption of soft drinks increases ulcerative colitis
  3. Children and adolescents with ADHD have a deficiency in n-3 PUFAs levels
  4. Subjects with end-stage renal disease benefit from a diet with <5.5 En% protein
  5. Resveratrol supplementation ≥3 months has favorable effects on several risk factors of non-communicable diseases
  6. 500 mg/day quercetin reduce circulating C-reactive protein levels
  7. Asthma increases risk of cardiovascular disease and all-cause mortality in women
  8. Improving iron status decreases fatigue in patients with iron deficiency without anaemia
  9. High sucrose intake might increase the risk of Crohn’s disease
  10. Daily 1-2g L-carnitine supplementation reduce inflammation
  11. Decreased vitamin D levels and increased BMI increase pediatric-onset MS
  12. Lower serum zinc levels increase Parkinson's disease
  13. Decreased folate level is a risk factor for schizophrenia
  14. Coenzyme Q10 supplementation may decrease inflammation
  15. Marine oil supplements alleviate pain in rheumatoid arthritis patients
  16. Serum vitamin D ≥75 nmol/L reduces risk of allergic rhinitis in men

2016:

  1. Daily 3 cups of tea decrease risk of depression

2015:

  1. 500-1000 mg/day oral ginger intake reduce pain in osteoarthritis patients
  2. Ultrasound can detect active Crohn’s disease in adults

XXXXXXXXXXXXXXXX

Chronic diseases, also known as noncommunicable diseases (NCDs) are diseases caused by inflammation in the human body. Inflammation is caused by the actions of free radicals or eicosanoids, which are produced from the fatty acid arachidonic acid. While the eicosanoids produced from arachidonic acid are pro-inflammatory, are the eicosanoids produced from EPA anti-inflammatory.
Arachidonic acid is found in meat, eggs, dairy products, and fish. The WHO and the EFSA have not set nutritional recommendation for dietary arachidonic acid yet.

Chronic diseases generally cannot be prevented by vaccines or cured by medication nor do they just disappear. Chronic diseases tend to become more common with age.

Free radicals are caused by the inhalation of cigarette smoke, diseases, physical exercises, smog, fine particles, high-fat products and exhaust gases. Free radicals can be neutralized by antioxidants. But scientific studies showed that taking antioxidant supplements will cause more harm than good. Therefore, nutritionists recommend to get antioxidants from diet rather than from dietary supplements. Antioxidants are found in vegetables, fruits and nuts.

Scientific studies showed that an n3:n6 ratio of 1 to 5 or less possible prevents chronic diseases. However, the WHO and the EFSA have not set specific values for the n3:n6 ratio yet.

Chronic diseases are:

  • Autoimmune diseases (AID)
  • Diabetes
  • Brain disorders (epilepsy, Parkinson's disease)
  • Cancer
  • Joint disorders (rheumatism, gout and arthritis)
  • Heart diseases
  • Kidney diseases
  • Lung diseases (asthma and COPD)
  • Mental disorders

Dietary guidelines for chronic disease prevention:

  • Choose products with maximum 30-35 En% fat, products with maximum 7-10 En% saturated fat, products with maximum 0.3 gram of salt per 100 kcal, products with minimum 1.5 grams of fiber per 100 kcal, products with a GI-number of 55 or lower and fishes providing at least 2000 mg EPA and DHA per day or in other words, your daily diet (=all meals/products that you eat on a daily basis) should on average contain maximum 30-35 En% fat, maximum 7-10 En% saturated fat, maximum 0.3 gram of salt per 100 kcal and minimum 1.5 grams of fiber per 100 kcal.
  • Stop smoking because cigarette smoke contains/causes free radicals.
  • Aim for a healthy weight. A healthy weight has a BMI of 18.5-25. BMI is weight divided by height squared (weight (kg)/height2 (m)).
    Overweight is a risk factor for certain chronic diseases.
  • Spend at least 60-90 minutes of physical activities per day or at least 10000 steps per day.
  • Eat at least 3 times (100-150 g fish per time) a week oily fish. Oily fishes are sardines, herring, salmon, anchovies, eel and mackerel.
  • Eat 300 grams of vegetables and five servings of fruit a day or 30-40 grams of fiber per day.
    40 grams of fiber per dag corresponds to a daily diet of minimum 2 grams of fiber per 100 kcal.
  • Take when needed glucosamine supplements. Take supplements always after consultation with an expert!
  • Do not take antioxidant supplements because they do more harm than good!

Diabetes

Scientific studies (review articles) on the relationship between diet/nutrients and diabetes prevention:
One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of randomized, placebo-controlled double blind clinical trials (RCTs) will answer the following question:
"Do taking dietary supplements make sense?" Yes for a positive conclusion and no for a negative conclusion.

One swallow does not make a summer. A famous Dutch saying that could not be any more obvious. Just because one single scientific study about a certain topic makes certain claims, it does not necessarily mean it is true. On the other hand, a review article (a collection of scientific studies on a certain topic) of cohort studies or case-control studies will answer the following question:
"Should I change my diet?".

2022:

  1. 500 mg/d dietary flavonoid intake reduces cardiovascular disease, diabetes and hypertension
  2. Vitamin D deficiency increases blindness in people with diabetes
  3. 50 g/d almond decreases causally bad cholesterol in patients with type 2 diabetes
  4. Ginger supplementation reduces blood pressure in patients with type 2 diabetes

2021:

  1. Higher concentrations of carotenoids reduce type 2 diabetes
  2. Dietary sodium restriction causally reduces blood pressure in patients with type 2 diabetes mellitus
  3. Daily 80g potato increase type 2 diabetes among Western populations
  4. Vitamin C supplements improve triglyceride and cholesterol levels in patients with type 2 diabetes mellitus
  5. Spirulina supplementation reduces bad cholesterol among type 2 diabetes patients
  6. Grapes/grape products supplementation reduces HOMA-IR values in adults
  7. Intensive glucose control slows down cognitive decline in persons with type 2 diabetes
  8. Chromium supplementation improves lipid profile in patients with type 2 diabetes mellitus
  9. Patients with diabetes mellitus should be vaccinated against herpes zoster
  10. L-arginine supplements do not reduce diabetes in adults
  11. 1.5 g/day garlic supplementation reduces adiponectin level among participants ˂30 years
  12. Mortality is more frequently in COVID-19 patients with chronic kidney diseases and cardiovascular disease
  13. Peanut butter consumption may reduce type 2 diabetes
  14. Patients older than 60 years, with hypertension, diabetes and D-dimer values above 3.17 µg/mL have higher thrombotic events due to COVID-19
  15. Diet with <30 En% carbohydrates causally increases adiponectin concentration in adults
  16. 1.5 g/day EPA + DHA improve insulin sensitivity in children
  17. Oral vitamin C supplementation may improve glycemic control and blood pressure in people with type 2 diabetes
  18. Type 1 diabetes mellitus decreases bone mineral density in children and adolescents

2020:

  1. BCG vaccine should not be used in treatment of type 1 diabetes mellitus
  2. 2-3 servings/week fish reduce all-cause mortality in patients with type 2 diabetes
  3. Most prevalent comorbidities among COVID-19 are hypertension, diabetes, cardiovascular disease, liver disease, lung disease, malignancy, cerebrovascular disease, COPD and asthma
  4. Vitamin B3 supplementation increases good cholesterol in patients with type 2 diabetes mellitus
  5. Patients with diabetes should be advised to continue taking metformin drugs despite COVID-19 infection status
  6. Daily 8.4-10 grams of inulin supplements for at least 8 weeks improve risk factors of type 2 diabetes
  7. Male, age, cardiovascular disease, hypertension and diabetes mellitus increase mortality in patients with COVID-19
  8. Diabetes mellitus is associated with severe infection and mortality in patients with COVID-19
  9. Barberry supplementation improves insulin levels
  10. Diabetes increases in-hospital mortality in patients with COVID-19
  11. Daily 40g soy consumption for <12 weeks increase IGF-1 level
  12. 100 mg/day magnesium dietary intake reduce type 2 diabetes
  13. 50g/day processed meat increase type 2 diabetes
  14. Yogurt intake is associated with a reduced risk of type 2 diabetes
  15. Hypertension, diabetes, COPD, cardiovascular disease and cerebrovascular disease are major risk factors for patients with COVID-19
  16. Hypertension, cardiovascular diseases, diabetes mellitus, smoking, COPD, malignancy and chronic kidney disease are risk factors for COVID-19 infection
  17. Omega-3 fatty acids + vitamin E or D reduce gestational diabetes
  18. Psyllium consumption improves risk factors of diabetes
  19. Soy protein dietary intake reduces type 2 diabetes

2019:

  1. Elevated serum/plasma zinc concentration increases risk of type 2 diabetes
  2. 100mg magnesium dietary intake reduce type 2 diabetes
  3. Consumption of tree nuts decreases HOMA-IR and fasting insulin levels
  4. Low-fat dairy products have a beneficial effect on HOMA-IR, waist circumference and body weight
  5. Whole grain and cereal fiber dietary intake reduce type 2 diabetes
  6. Dietary low-ratio n-6/n-3 PUFA supplementation improves insulin resistance in diabetic patients
  7. Zinc supplementation reduces diabetes mellitus
  8. Moderate plant protein decreases type 2 diabetes mellitus
  9. Probiotic and synbiotic supplementation reduce inflammation in diabetic patients
  10. Folate supplementation lowers HOMA-IR
  11. 13.1 g/day viscous fiber supplements improve glycemic control

2018:

  1. 1 serving/day potato increases risk type 2 diabetes
  2. 150 g/day French-fries consumption increases risk of hypertension
  3. Garlic increases good cholesterol in diabetic patients
  4. High intake of cereal fiber may reduce type 2 diabetes
  5. Ginger intake reduces body weight and fasting glucose among overweight and obese subjects
  6. Animal protein increases risk of type 2 diabetes
  7. ≥550 mg/day flavonoids intake reduce type 2 diabetes
  8. High-fat diets increase risk of type 2 diabetes
  9. Folic acid supplementation reduces both fasting glucose level, fasting insulin level and HOMA-IR
  10. Low-GI diet is good for patients with type 2 diabetes
  11. Vitamin K supplementation has no effect on glycemic control
  12. Daily 3 mg L-carnitine during 12 weeks reduce serum leptin concentrations in diabetic patients

2017:

  1. Each 1 mmol/L increase in serum potassium reduces type 2 diabetes mellitus by 17%
  2. Fish oil supplementation during <12 weeks improves insulin sensitivity among people with metabolic disorders
  3. Atrial fibrillation, previous stroke, myocardial infarction, hypertension, diabetes and previous TIA increase risk of post-stroke dementia
  4. Pomegranate supplementation has no favourable effect on improvements in glucose and insulin metabolism
  5. Low carbohydrate diet decreases type 2 diabetes
  6. A diet with 4.4 g/day alpha-linolenic acid during 3 months does not reduce level of HbA1c, FBG or FBI in patients with type 2 diabetes
  7. Vegetarian diet has a protective effect against diabetes risk
  8. Weekly 30-180 gram chocolate consumption reduces risk of coronary heart disease, stroke and diabetes
  9. Probiotics supplementation improves HbA1c and fasting insulin in type 2 diabetes patients
  10. Vitamin K supplementation does not reduce diabetes
  11. A higher consumption of whole grains, fruits and dairy products reduces type 2 diabetes risk
  12. A diet of below 45 En% carbohydrate during 3 to 6 months reduces HbA1c level of patients with type 2 diabetes
  13. Vitamin C supplementation for at least 30 days reduces glucose concentrations in patients with type 2 diabetes
  14. Magnesium supplementation reduces risk of cardiovascular disease among type 2 diabetes
  15. Weekly one serving of apple and pear reduces type 2 diabetes mellitus risk
  16. Reduced serum levels of folate and vitamin B12 increase peripheral neuropathy risk among patients with type 2 diabetes
  17. Vitamin C and D reduce blood pressure in patients with type 2 diabetes

2016:

  1. A higher intake of plant protein decreases risk of type 2 diabetes among women

2015:

  1. Garlic supplementation during 12 weeks reduces fasting blood glucose

2014:

  1. Exercise lowers the risk for diabetes conferred by insulin resistance
  2. 1-6 cups/day caffeinated or decaffeinated coffee is associated with reduced type 2 diabetes risk
  3. Exercise training helps to prevent and to treat type 2 diabetes in youth
  4. At least 25g dietary fiber intake per day reduces risk of type 2 diabetes
  5. Niacin supplementation reduces LDL cholesterol levels in patients with type 2 diabetes mellitus

2012:

Diabetes increases risk of dementia and mild cognitive impairment

XXXXXXXXXX

The human body wants the blood glucose (blood sugar) level maintained in a very narrow range of 4 to 8 mmol/l. Insulin and glucagon are the hormones which make this happen. Both insulin and glucagon are secreted from the pancreas.

When the blood glucose level drops below 4 mmol/l (after physical exercise or on awakening) the alpha cells of the pancreas release glucagon. Glucagon converts glycogen into glucose. The glucose is released into the bloodstream, increasing blood sugar levels.
On the other hand, when the blood glucose level rises above 8 mmol/l, whether as a result of glycogen conversion or from digestion of a meal, insulin is released from beta cells of the pancreas. This hormone causes the liver to convert more glucose into glycogen and to force about 2/3 of body cells to take up glucose from the bloodstream through the GLUT4 transporter, thus decreasing blood sugar levels.

Diabetes mellitus describes a group of chronic metabolic diseases in which the person has a high blood glucose level, either because insulin production is inadequate or because the body's cells do not respond properly to insulin (also called insulin resistance) or both. Diabetes can be divided into two types: type 1 and type 2.

Type 1 diabetes:
The human body does not produce insulin. This type of diabetes is also called insulin-dependent diabetes, juvenile diabetes or early-onset diabetes. People usually develop type 1 diabetes before their 40th year, often in early adulthood or teenage years.

Patients with type 1 diabetes will need to take insulin injections for the rest of their life. They must also ensure proper blood-glucose levels by carrying out regular blood tests and following a special diet. Type 1 diabetes is not curable and is generally a form which is less common than type 2.

Type 2 diabetes:
In type 2 diabetes the body does not respond properly to insulin. Type 2 diabetes occurs mainly in the elderly and in people who are overweight (BMI>25). The treatment of type 2 diabetes is the first of dietary advice in conjunction with achieving a healthy weight (BMI = 18.5-25). Unlike type 1, type 2 is curable. Type 2 diabetes is also referred to as non-insulin-dependent diabetes mellitus.

Approximately 90% of all cases of diabetes worldwide are of this type.

These are the consequences that many diabetics may experience:

  • Amputation of limbs
  • Depression
  • Heart diseases
  • Skin problems
  • Gastrointestinal problems
  • Kidney disease
  • Eye problems
  • Problems of the joints
  • Problems with brains
  • Sexual problems
  • Foot problems
  • Nerves disorders

Dietary guidelines for diabetes prevention:

  • Choose products with minimum 1.5 grams of fiber per 100 kcal, products with maximum 30 En% fat, products with maximum 7 En% saturated fat, products with 10-20 En% protein, products with maximum 10 En% sugars and products with a low GI value (55 or lower) or in other words, your daily diet (=all meals/products that you eat on a daily basis) should on average contain minimum 1.5 grams of fiber per 100 kcal, maximum 30 En% fat, maximum 7 En% saturated fat, 10-20 En% protein and maximum 10 En% sugars.
  • Aim for a healthy weight. A healthy weight has a BMI of 18.5-25. BMI is weight divided by height squared (weight (kg)/height2 (m)).
  • Spend at least 60-90 minutes of physical activities per day or at least 10000 steps per day.
  • Eat at least 3 times (100-150 g fish per time) a week oily fish. Oily fishes are sardines, herring, salmon, anchovies, eel and mackerel. Oily fish contains more EPA and DHA than non-oily fish.
  • Eat 300 grams of vegetables and five servings of fruit a day or 30-40 grams of fiber per day.
    40 grams of fiber per dag corresponds to a daily diet of minimum 2 grams of fiber per 100 kcal.
  • Eat plenty of whole grains, such as brown bread and oatmeal and legumes.
  • Limit to 2-3 glasses of alcohol for men and 1-2 glasses for women a day or <30 g alcohol per day.

High β-carotene dietary intake reduces Parkinson's disease among women

Objectives:
Does high-dose dietary intake of vitamin E, β-carotene or vitamin C reduce risk of Parkinson's disease?

Study design:
This review article included 13 observational studies.

Results and conclusions:
The investigators found no significant association between high-dose vitamin C dietary intake and the risk of Parkinson's disease compared with low-dose vitamin C dietary intake [RR = 0.98, 95% CI = 0.89 to 1.08].

The investigators found compared with low-dose dietary intake, high-dose dietary intake of vitamin E significantly reduced risk of Parkinson's disease with 13% [RR = 0.87, 95% CI = 0.77 to 0.99].

The investigators found compared with low-dose dietary intake, high-dose dietary intake of β-carotene significantly reduced risk of Parkinson's disease among women with 22% [RR = 0.78, 95% CI = 0.64 to 0.96].

The investigators concluded both high-dose dietary intake of vitamin E and β-carotene (beta-carotene) reduce risk of Parkinson's disease.

Original title:
Vitamin C, vitamin E, β-carotene and risk of Parkinson's disease: a systematic review and dose-response meta-analysis of observational studies by Niu F, Xie W, […], Yu X.

Link:
https://pubmed.ncbi.nlm.nih.gov/36961747/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant, vitamin C, E, beta-carotene and Parkinson’s disease.
 

50g/d legume dietary intake may reduce mortality from all causes

Objectives:
There is an equivocal and inconsistent association between legume consumption and health outcomes and longevity. Therefore, this review article has been conducted.

Does a higher legume dietary intake reduce mortality and stroke risk?

Study design:
This review article included 32 cohort studies (31 publications) involving 1,141,793 participants and 93,373 deaths from all causes (all-cause mortality).

The certainty of evidence was judged from low to moderate.

Results and conclusions:
The investigators found higher dietary intakes of legumes, compared with lower dietary intakes, were significantly associated with a reduced risk of 6% for mortality from all causes [HR = 0.94, 95% CI = 0.91 to 0.98, n = 27].

The investigators found higher dietary intakes of legumes, compared with lower dietary intakes, were significantly associated with a reduced risk of 9% for stroke [HR = 0.91, 95% CI = 0.84 to 0.99, n = 5].

The investigators found no significant association for cardiovascular diseases mortality [HR = 0.99, 95% CI = 0.91 to 1.09, n =11], coronary heart disease mortality [HR = 0.93, 95% CI = 0.78 to 1.09, n = 5] or cancer mortality [HR = 0.85, 95% CI = 0.72 to 1.01, n = 5].

The investigators found in the linear dose-response analysis, a 50 g/d increase in legume dietary intake was significantly associated with a 6% reduction in the risk of all-cause mortality [HR = 0.94, 95% CI = 0.89 to 0.99, n = 19], but no significant association was observed for the remaining outcomes.

The investigators concluded a higher legume dietary intake may reduce mortality from all causes and stroke risk. May reduce because the certainty of evidence is low to moderate.

Original title:
Legume Consumption and Risk of All-Cause and Cause-Specific Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies by Zargarzadeh N, Mousavi SM, […], Esmaillzadeh A.

Link:
https://pubmed.ncbi.nlm.nih.gov/36811595/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant, vegetable intake and stroke prevention.
 

Fish consumption reduces Alzheimer's disease

Objectives:
Current findings about the differential effects of various sources of dietary animal protein on the risk of neurodegenerative diseases are contradictory. Therefore, this review article has been conducted.

Is there an association between various sources of dietary animal protein and the risk of Parkinson's disease, Alzheimer's disease, dementia and cognitive impairment?

Study design:
This review article included 33 prospective cohort studies.

Results and conclusions:
The investigators found dietary fish consumption was significantly associated with a reduced risk of 25% for Alzheimer's disease [RR = 0.75, 95% CI = 0.57 to 0.97].

The investigators found dietary fish consumption was significantly associated with a reduced risk of 16% for dementia [RR = 0.84, 95% CI = 0.75 to 0.93].

The investigators found dietary fish consumption was significantly associated with a reduced risk of 15% for cognitive impairment [RR = 0.85, 95% CI = 0.81 to 0.95].

The investigators found compared to the lowest consumption, the highest total dairy products consumption was significantly associated with an increased risk of 49% for Parkinson's disease [RR = 1.49, 95% CI = 1.06 to 2.10].

The investigators found compared to the lowest consumption, the highest milk consumption was significantly associated with an increased risk of 40% for Parkinson's disease [RR = 1.40, 95% CI = 1.13 to 1.73].

The investigators found total dairy products consumption was significantly associated with a reduced risk of 11% for cognitive impairment [RR = 0.89, 95% CI = 0.80 to 0.99].

The investigators found total meat consumption was significantly associated with a reduced risk of 28% for cognitive impairment [RR = 0.72, 95% CI = 0.57 to 0.90].

The investigators found poultry consumption was significantly associated with a reduced risk of 18% for cognitive impairment [RR = 0.82, 95% CI = 0.68 to 0.99].

The investigators found linear dose-response meta-analysis revealed that each 200g/d increase in total dairy dietary intake was significantly associated with an 11% higher risk of Parkinson's disease and a 12% lower risk of cognitive impairment.

The investigators found a strong linear association between fish consumption and reduced risk of dementia.

The investigators concluded dairy consumption, particularly milk is associated with an increased risk of Parkinson's disease, while a higher intake of fish reduces Alzheimer's disease, dementia and cognitive impairment. Future well-controlled, randomized clinical trials are essential to validate the present findings.

Original title:
Association between animal protein sources and risk of neurodegenerative diseases: a systematic review and dose-response meta-analysis by Talebi S, Asoudeh F, […], Mohammadi H.

Link:
https://pubmed.ncbi.nlm.nih.gov/36647769/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant, dairy product, Parkinson's disease and proteins.
 

Selenium supplementation reduces postpartum depression

Objectives:
The results of human studies are inconsistent regarding selenium and depressive disorders. Therefore, this review article has been conducted.

Does high selenium intake (through diet or supplements) reduce risk of depression?

Study design:
This review article included 20 studies (4 RCTs, 9 cross-sectional studies, 4 case-control studies and 3 prospective cohort studies) with a total of 47,164 participants.
The age of participants ranged from 18.0 ± 1.2 to 82 years old.
12 studies included both men and women.
Confounding variables were adjusted in half of included studies.
All included randomized controlled trials (RCTs) had high quality.
There was no publication bias.

Results and conclusions:
The investigators found no significant differences in serum selenium levels between patients with depression and healthy subjects [WMD = 2.12 mg/L, 95% CI = -0.11 to 4.36, I2 = 98.0%, p 0.001].

The investigators found no significant differences between serum levels of selenium and depression scores [r = -0.12, 95% CI = -0.33 to 0.08, I2 = 73.5%, p = 0.010].

The investigators found high selenium supplementation significantly reduced the risk of postpartum depression with 3% [OR = 0.97, 95% CI = 0.95 to 0.99, I2 = 0.0%, p = 0.507].

The investigators found selenium supplementation significantly reduced depressive symptoms [WMD = -0.37, 95% CI = -0.56 to -0.18, I2 = 0.0%, p = 0.959].

The investigators concluded that high selenium supplementation has a protective role against postpartum depression. In addition, supplementation with selenium reduces depressive symptoms. Nevertheless, further studies are needed to draw definitive conclusions.

Original title:
The role of selenium in depression: a systematic review and meta-analysis of human observational and interventional studies by Sajjadi SS, Foshati S, […], Rouhani H.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776795/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant and selenum intake.

 

Tomato intake causally reduces TNF-α levels in adults

Objectives:
Inflammation is a major cause of chronic diseases. Several studies have investigated the effects of tomato intake on inflammatory biomarkers; however, the results are equivocal. Therefore, this review article has been conducted.

Does tomato intake have positive impact on inflammatory biomarkers in adults?

Study design:
This review article included 7 RCTs (8 treatment arms) with a total of 465 subjects.

Results and conclusions:
The investigators found that pooled effect size of articles indicated that tomato intake was not significantly effective on CRP [WMD = 0.13 mg/dL, 95% CI = -0.09 to 0.36, p = 0.23, I2 = 83.9%] and IL-6 [Hedges' g = -0.12, 95% CI = -0.36 to 0.13, p = 0.34, I2 = 0.0%] levels compared to the control group.

The investigators found that pooled effect size of articles indicated that tomato intake significantly reduced TNF-α [Hedges' g = -0.45, 95% CI = -0.76 to -0.13, p = 0.005, I2 = 0.0%] levels in adults.

The investigators concluded that tomato intake causally reduces TNF-α levels in adults. However, additional well-designed studies that include more diverse populations and longer duration are warranted.

Original title:
Effect of tomato consumption on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials by Widjaja G, Doewes RI, […], Aravindhan S.

Link:
https://pubmed.ncbi.nlm.nih.gov/35871957/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant, and tomato intake.

Tumor necrosis factor alpha (TNF-α) is an inflammatory cytokine that is elevated in heart failure.

400 mg/day vitamin C supplementation improves lung function of COPD patients

Objectives:
Do COPD patients benefit from vitamin C supplementation?

Study design:
This review article included 10 RCTs with a total of 487 patients.

Results and conclusions:
The investigators found that vitamin C supplementation (≥400 mg/day) significantly improved the forced expiratory volume in one second as a percentage (FEV1%) of COPD patients [SMD = 1.08, 95% CI = 0.03 to 2.12, p = 0.04].

The investigators found, moreover, vitamin C supplementation (≥400 mg/day) significantly improved the ratio of forced expiratory volume in 1 second and forced vital capacity (FEV1/FVC) [WMD = 0.66, 95% CI = 0.26 to 1.06, p = 0.001], vitamin C level in serum [SMD = 0.63, 95% CI = 0.02 to 1.24, p = 0.04] and glutathione (GSH) level in serum [SMD = 2.47, 95% CI = 1.06 to 3.89, p = 0.0006] of COPD patients.

The investigators found no statistically significant difference was observed in body mass index (BMI), fat-free mass index (FFMI), vitamin E level and superoxide dismutase (SOD) level in serum.

The investigators concluded vitamin C supplementation increases the levels of antioxidation in serum (vitamin C and GSH) and improves lung function (FEV1% and FEV1/FVC) of COPD patients, especially when treated with vitamin C supplementation greater than 400 mg/day. However, further prospective studies are needed to explore the role of vitamin C in improving nutritional status.

Original title:
Efficacy of Vitamin C Supplementation on Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis by Lei T, Lu T, […], Liu J.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473551/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant and vitamin C.

Vitamin E supplements enhance quality of life of rheumatoid arthritis patients

Objectives:
Do rheumatoid arthritis patients benefit from vitamin E supplements?

Study design:
This review article included 9 RCTs with a total of 39,845 patients.

Results and conclusions:
The investigators found that vitamin E supplements were shown to be more effective in individuals with rheumatoid arthritis for sensitive joints [MD = -1.66, 95% CI = -6.32 to -2.99, I2 = 93%, p 0.00001] and swollen joints [MD = -0.46, 95% CI = -1.98 to 1.07, I2 = 56%, p = 0.08].

The investigators concluded vitamin E's ability to restore the intestinal barrier and improve the gastrointestinal tract may be linked to the prevention and treatment of rheumatoid arthritis. Vitamin E supplements used on a regular basis can help individuals with rheumatoid arthritis reduce joint discomfort, edema and stiffness, as well as enhance their overall quality of life.

Original title:
Effect of vitamin E supplementation in rheumatoid arthritis: a systematic review and meta-analysis by Kou H, Qing Z, […], Ma J.

Link:
https://pubmed.ncbi.nlm.nih.gov/35468933/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant and vitamin E.

 

Vitamin D deficiency increases blindness in people with diabetes

Objectives:
Vitamin D levels have been shown to be associated with diabetic retinopathy, however to date, no review has examined the relationship between vitamin D and sight threatening diabetic retinopathy (STDR) and non-sight threatening diabetic retinopathy (NSTDR). Therefore, this review article has been conducted. 

Does vitamin D deficiency (defined as 25(OH)D levels of 20 ng/mL) increase risk of diabetic retinopathy in patients with diabetes?

Study design:
This review article included 11 cross-sectional studies and 1 case-control study with a total of  9,057 participants.
There was no publication bias.

Results and conclusions:
The investigators found vitamin D deficiency significantly increased risk of sight threatening diabetic retinopathy with 80% [OR = 1.80, 95% CI = 1.40 to 2.30, p ≤ 0.001, I2 = 39.39%].
However, this increased risk was not found for non-sight threatening diabetic retinopathy [OR = 1.10, 95% CI = 0.90 to 1.27, p = 0.48, I2 = 30.21%].

The investigators concluded that vitamin D deficiency (defined as 25(OH)D levels of 20 ng/mL)  increases risk of sight threatening diabetic retinopathy but not non-sight threatening diabetic retinopathy. Given the well-reported associations between vitamin D deficiency and other unfavourable outcomes, it is important that vitamin D deficiency is managed appropriately and in a timely manner to reduce the risk of blindness in people with diabetes.

Original title:
Associations between vitamin D status and sight threatening and non-sight threatening diabetic retinopathy: a systematic review and meta-analysis by Trott M, Driscoll R, […], Pardhan S.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167360/

Additional information of El Mondo:
Find more information/studies on vitamin D and diabetes right here.

Diabetic retinopathy, also known as diabetic eye disease (DED), is a complication of diabetes, caused by high blood sugar levels damaging the back of the eye (retina). It can cause blindness if left undiagnosed and untreated.

 

Meat intake may increase kidney stones

Objectives:
What is the association of total protein, animal protein and animal protein sources with risk of kidney stones in the general population?

Study design:
This review article included 14 prospective cohort studies.
According to NutriGrade scoring system, the credibility of evidence for most of the exposures was rated as low.
Some kind of publication bias was found in the association of animal protein intake and risk of kidney stones, according to Egger's and Begg's tests.
Sensitivity analysis of processed meat as well as dairy consumption with risk of kidney stones showed one study changed the overall estimate.

Results and conclusions:
The investigators found that higher dietary intake of non-dairy animal protein significantly increased risk of kidney stones with 11% [RR = 1.11, 95% CI = 1.03 to 1.20, I2 = 0%, n = 4].
Significant means that there is an association with a 95% confidence.

The investigators found that higher dietary intake of total meat and meat products significantly increased risk of kidney stones with 22% [RR = 1.22, 95% CI = 1.09 to 1.38, I2 = 13%, n = 3].
Significant because RR of 1 was not found in the 95% CI of 1.09 to 1.38. RR of 1 means no risk/association.

The investigators found that higher dietary intake of processed meat significantly increased risk of kidney stones with 22% [RR = 1.22, 95% CI = 1.10 to 1.51, I2 = 0%, n = 2]. 

The investigators found that higher intake of dairy protein significantly decreased risk of kidney stones with 9% [RR = 0.91, 95% CI = 0.84 to 0.99, I2 = 0%, n = 4].

The investigators found, moreover, each 100 gram increment of red meat dietary intake was significantly associated with an increased risk of 39% for kidney stones [RR = 1.39, 95% CI = 1.13 to 1.71].

The investigators concluded that higher dietary intake of meat and meat products may increase the risk of kidney stones in the general population, while higher dietary intake of dairy proteins may decrease the risk of kidney stones in the general population. May because the credibility of evidence for most of the exposures was rated as low and there was publication bias. Therefore, further observational studies are needed to confirm present results.

Original title:
Associations of Total Protein or Animal Protein Intake and Animal Protein Sources with Risk of Kidney Stones: A Systematic Review and Dose-Response Meta-Analysis by Asoudeh F, Talebi S, […], Mohammadi H.

Link:
https://pubmed.ncbi.nlm.nih.gov/35179185/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant, meat and dairy consumption.

When the credibility of evidence of the studies in the review article is low and there is publication bias, the results will not be very reliable.
 

50 g/d almond decreases causally bad cholesterol in patients with type 2 diabetes

Objectives:
An enhanced risk for cardiovascular disease (CVD) still exists even when patients with type 2 diabetes have tight control on blood sugar. Thus, identification of treatment approaches that address CVD risk factors may be useful for patients beyond the blood sugar management. Although emerging evidence suggests that nuts consumption have beneficial effects on cardiometabolic health, the effects of almond intake in patients with type 2 diabetes are still controversial. Therefore, this review article has been conducted. 

Does almond consumption improve risk factors (cholesterol, triglycerides, fasting plasma glucose, insulin, hemoglobin A1c (HbA1c), body mass index, weight, body fat, systolic and diastolic blood pressure and CRP) of cardiovascular disease in patients with type 2 diabetes?

Study design:
This review article included 9 RCTs.

Results and conclusions:
The investigators found there was a causal relationship between almond dietary intake and a  significant reduction in low-density lipoprotein cholesterol (LDL cholesterol or bad cholesterol) [WMD = -5.28 mg/dL, 95% CI = -9.92 to -0.64, p = 0.026] in patients with type 2 diabetes compared with the control group.
This lowering effect of LDL cholesterol was robust in subgroups with almond consumption >50 g/day and baseline LDL cholesterol level 130 mg/dL.

The investigators found, however, the effect of almond on total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL cholesterol or good cholesterol), fasting plasma glucose, insulin, HbA1c, body mass index, weight, body fat, systolic and diastolic blood pressure and CRP was not significant compared with the control group.

The investigators concluded that a dietary intake of at least 50 g/d almond decreases causally LDL cholesterol (bad cholesterol) but has no favourable effect on other cardiometabolic outcomes in patients with type 2 diabetes. Further high-quality studies are needed to firmly establish the clinical efficacy of the almond.

Original title:
Effects of almond on cardiometabolic outcomes in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials by Moosavian SP, Rahimlou M, […], Jalili C.

Link:
https://pubmed.ncbi.nlm.nih.gov/35443097/

Additional information of El Mondo:
Find more information/studies on almond consumption and diabetes right here.
 

High-dose dietary intake of vitamins A and B reduces glaucoma

Objectives:
There is currently a lack of high-quality research on the best dietary recommendations for patients with early glaucoma or at high risk for glaucoma. Therefore, this review article has been conducted.

Does a high dietary vitamin intake reduce risk of glaucoma?

Study design:
This review article included 8 cohort studies, with a total of 262,189 patients.

There was no publication bias.

Results and conclusions:
The investigators found that high-dose dietary intake of vitamins A was significantly associated with a 27% low risk of glaucoma [OR = 0.63, 95% CI = 0.53 to 0.76 , p 001, I2 = 49%].

The investigators found that high-dose dietary intake of vitamins B (a combination of B1, B2, B3, B6 and B12) was significantly associated with a 29% low risk of glaucoma [OR = 0.71, 95% CI = 0.64 to 0.80, p 0.001, I2 = 29%].

The investigators found no association between high-dose dietary intake of vitamins C, D or E and lower risk of glaucoma.

The investigators concluded that high-dose dietary intake of vitamins A and B, but not vitamins C, D or E, is associated with a low prevalence of glaucoma. Overall, middle-aged and elderly people or patients with early glaucoma should consume vitamin-rich foods rich or take additional vitamin supplements.

Original title:
Vitamin intake and glaucoma risk: A systematic review and meta-analysis by Han FF and Fu XX.             

Link:
https://www.sciencedirect.com/science/article/pii/S0181551222000419?via%3Dihub

Additional information of El Mondo:
Find here more information/studies about chronic diseases, vitamin A and B.
 

Ginger supplementation reduces blood pressure in patients with type 2 diabetes

Objectives:
There is some evidence regarding the positive effects of ginger supplementation on metabolic profile in patients with type 2 diabetes (T2DM). However, they are conflicting and therefore, this review article has been conducted. 

Does ginger supplementation improve metabolic profile (FBS, HbA1c, TC, TG, LDL, HDL, SBP and DBP) in patients with type 2 diabetes?

Study design:
This review article included 10 RCTs.

Results and conclusions:
The investigators found pooled meta-analysis showed a significant reduction in fasting blood sugar (FBS) level following ginger supplementation by polling 8 effect sizes [WMD = -18.81, 95% CI = -28.70 to -8.92, I2 = 77.4%].

The investigators found pooled meta-analysis showed a significant reduction in HbA1c level following ginger supplementation by polling 7 effect sizes [WMD = -0.57, 95% CI = -0.93 to -0.20, I2 = 88.6%].

The investigators found pooled meta-analysis showed a significant reduction in systolic blood pressure (SBP) following ginger supplementation by polling 5 effect sizes [WMD = -4.20, 95% CI = -7.64 to -0.77, I2 = 97%].

The investigators found pooled meta-analysis showed a significant reduction in diastolic blood pressure (DBP) following ginger supplementation by polling 5 effect sizes [WMD = -1.61, 95% CI = -3.04 to -0.18, I2 = 93.2%].

The investigators found pooled meta-analysis showed ginger supplementation had no significant influence on lipid profile involving triglyceride (TG), total cholesterol (TC), LDL cholesterol and HDL cholesterol.

The investigators concluded supplementation with ginger reduces fasting blood sugar, HbA1c, systolic blood pressure and diastolic blood pressure in patients with type 2 diabetes. Further large RCTs are required to shed light on this issue.

Original title:
The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials by Ebrahimzadeh A, Ebrahimzadeh A, […], Milajerdi A.

Link:
https://pubmed.ncbi.nlm.nih.gov/35031435/

Additional information of El Mondo:
Find more information/studies on lowering blood pressure and diabetes right here.
 

Higher intake of antioxidant-rich foods reduces Parkinson's disease

Objectives:
Does a higher intake of dietary antioxidants (like vitamin C and E, β-carotene, zinc, anthocyanins, lutein) reduce risk of Parkinson's disease (PD)?

Study design:
This review article included 6 prospective cohort studies and 2 nested case-control studies (448,737 participants with 4,654 persons with Parkinson's disease) and 6 case-control studies (1,948 persons without Parkinson's disease and 1, 273 persons with Parkinson's disease).

Results and conclusions:
The investigators found comparded to the lowest dietary vitamine E intake, that the highest dietary vitamine E intake significantly reduced risk of Parkinson's disease with 16% [pooled RR = 0.84, 95% CI = 0.71 to 0.99, n = 7 cohort studies].
Significantly means that there is an association with a 95% confidence.

The investigators found compared to the lowest dietary anthocyanins intake, that the highest dietary anthocyanins intake significantly reduced risk of Parkinson's disease with 24% [pooled RR = 0.76, 95% CI = 0.61 to 0.96, n = 2 cohort studies].
Significantly because pooled RR of 1 was not found in the 95% CI of 0.61 to 0.96. RR of 1 means no risk/association.

The investigators found compared to the lowest dietary lutein intake, that the highest dietary lutein intake significantly increased risk of Parkinson's disease with 86% [pooled RR = 1.86, 95% CI = 1.20 to 2.88, n = 3 case-control studies].

The investigators found in dose-response meta-analyses that every increment of dietary vitamin C intake with 50 mg/d significantly reduced risk of Parkinson's disease with 6% [RR = 0.94, 95% CI = 0.88 to 0.99, n = 6].

The investigators found in dose-response meta-analyses that every increment of dietary vitamin E intake with 5 mg/d significantly reduced risk of Parkinson's disease with 16% [RR = 0.84, 95% CI = 0.70 to 0.99, n = 7].

The investigators found in dose-response meta-analyses that every increment of dietary β-carotene intake with 2 mg/d significantly reduced risk of Parkinson's disease with 6% [RR = 0.94, 95% CI = 0.89 to 0.99, n = 6].

The investigators found in dose-response meta-analyses that every increment of dietary zinc intake with 1 mg/d significantly reduced risk of Parkinson's disease with 35% [RR = 0.65, 95% CI = 0.49 to 0.86, n = 1].

The investigators concluded that higher intake of antioxidant-rich foods reduces risk of Parkinson's disease. Future, well-designed prospective studies are needed to validate the present findings.

Original title:
Dietary Antioxidants and Risk of Parkinson's Disease: A Systematic Review and Dose-response Meta-analysis of Observational Studies by Talebi S, Ghoreishy SM, […], Mohammadi H.

Link:
https://pubmed.ncbi.nlm.nih.gov/35030236/

Additional information of El Mondo:
Find here more information/studies about RCTs/significant and antioxidants.
 

No difference in seroconversion between 3 doses of fIPV and 3 doses of full-dose poliovirus vaccine

Objectives:
Since WHO recommended introduction of at least a single dose of inactivated poliovirus vaccine (IPV) in routine immunisation schedules, there have been global IPV shortages. Fractional-dose IPV (fIPV) administration is one of the strategies to ensure IPV availability. Therefore, this review article has been conducted.

Is there a difference in seroconversion and antibodies response between fractional-dose IPV (fIPV) and full-dose IPV?

Study design:
This review article included 14 articles: 2 ongoing trials and 12 articles reporting on 10 completed studies.

The seroconversion meta-analysis for the three-dose comparison was homogeneous [p = 0.45, I2 = 0%], whereas heterogeneity was observed in the two-dose [p 0.00001, I2 = 88%] and one-dose [p = 0.0004, I2 = 74%] comparisons.
Heterogeneity was observed in meta-analyses of GMTs for one-dose [p 0.00001, I2 = 92%, two-dose [p = 0.002, I2 = 80%] and three-dose [p 0.00001, I2 = 93%] comparisons. Findings for types 1 and 3 were similar to those for type 2.
The certainty of the evidence was high for the three-dose comparisons and moderate for the rest of the comparisons.

Results and conclusions:
The investigators found for poliovirus type 2, there were no significant differences in the proportions of seroconversions between fractional and full doses of IPV for 2 or 3 doses: the risk ratio for serconversion at 1 dose was 0.61 [95% CI = 0.51 to 0.72], at 2 doses was 0.90 [95% CI = 0.82 to 1.00] and at 3 doses was 0.95 [95% CI = 0.91 to 1.00].

The investigators found geometric mean titres (GMTs) for poliovirus type 2 were lower for fIPV than for full-dose IPV [-0.51, 95% CI = -0.87 to -0.14] at 1 dose [-0.49, 95% CI = -0.70 to -0.28] at 2 doses and [-0.98, 95% CI = -1.46 to -0.51] at 3 doses.

The investigators concluded that there is no substantial difference in seroconversion between 3 doses of fractional-dose IPV (fIPV) and 3 doses of full-dose poliovirus vaccine (IPV), although the full dose gives higher titres of antibodies for poliovirus type 1, 2 and 3. Use of fractional IPV instead of the full dose can stretch supplies and possibly lower the cost of vaccination.

Original title:
Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis by Mashunye TR, Ndwandwe DE, [...], Wiysonge CS.

Link:
https://pubmed.ncbi.nlm.nih.gov/33939958/

Additional information of El Mondo:
Find more information/studies on RCTs/cohort/significantly/review article, vaccination and malnutrition right here.

Higher concentrations of carotenoids reduce type 2 diabetes

Objectives:
Previous meta-analysis studies have indicated inverse associations between some carotenoids and risks of metabolic syndrome, cardiovascular disease, cancer and all-cause mortality. However, the results for associations between carotenoids and type 2 diabetes (T2D) remain inconsistent and no systematic assessment has been done on this topic. Therefore, this review article (meta-analysis) has been conducted.

Do higher dietary intakes and circulating concentrations of carotenoids reduce risk of type 2 diabetes?

Study design:
This review article included 13 studies.

Results and conclusions:
The investigators found for the the highest versus the lowest categories of dietary intake of β-carotene a significantly reduced risk of 22% for type 2 diabetes [pooled RR = 0.78, 95% CI = 0.70 to 0.87, I2 = 13.7%, n = 6].
This significantly reduced risk was also found for total carotenoids (n = 2), α-carotene (n = 4), and lutein/zeaxanthin (n = 4), with pooled RRs ranging from 0.80 to 0.91, whereas no significant associations were observed for β-cryptoxanthin and lycopene.

The investigators found for the the highest versus the lowest categories of circulating concentration of β-carotene a significantly reduced risk of 40% for type 2 diabetes [pooled RR = 0.60, 95% CI = 0.46 to 0.78, I2 = 56.2%, n = 7].
This significantly reduced risk was also found for total carotenoids (n = 3), lycopene (n = 4), and lutein (n = 2), with pooled RRs ranging from 0.63 to 0.85, whereas no significant association was found for circulating concentrations of α-carotene and zeaxanthin when comparing extreme categories.

The investigators found dose-response analysis indicated that nonlinear relations were observed for circulating concentrations of α-carotene, β-carotene, lutein and total carotenoids [all p-nonlinearity 0.05], but not for other carotenoids or dietary exposures.

The investigators concluded that higher dietary intakes and circulating concentrations of total carotenoids, especially β-carotene, are associated with a lower risk of type 2 diabetes. More studies are needed to confirm the causality and explore the role of foods rich in carotenoids in prevention of type 2 diabetes.

Original title:
Dietary Intake and Circulating Concentrations of Carotenoids and Risk of Type 2 Diabetes: A Dose-Response Meta-Analysis of Prospective Observational Studies by Jiang YW, Sun ZH, [...], Pan A.

Link:
https://pubmed.ncbi.nlm.nih.gov/33979433/

Additional information of El Mondo:
Find more information/studies on carotenoids and diabetes right here.

 

0.8-10 mg/d folic acid supplements decrease CRP levels

Objectives:
It has been theorized that folic acid supplementation improves inflammation. However, its proven effects on inflammatory markers are unclear as clinical studies on this topic have produced inconsistent results. Therefore, this review article has been conducted.

Have folic acid supplements positive effects on inflammatory markers, like CRP, IL-6 and TNF-α?

Study design:
This review article included 12 RCTs with a total of 1,392 participants.
The studies were conducted between 2003 and 2018 and their sample size varied from 19 to 530 participants.
The mean age of the participants ranged from 24.1 to 68.1 years old.
The supplementation period ranged from 2 to 52 weeks.
The daily mentioned dosage of folic acid varied between 0.8 mg and 10 mg/d.

There was no publication bias.

Results and conclusions:
The investigators found a significant effect of folic acid supplementation on serum concentrations of CRP [WMD = -0.59 mg/L, 95% CI = -0.85 to -0.32, p 0.001, I2 = 91.3%, p 0.001].
This significantly reduced effect was also found in the subgroup and sensitivity analysis.
Subgroup analysis showed that baseline serum concentrations of CRP, duration of intervention, dosage and the participants’ age and gender explained this heterogeneity.

The investigators concluded that 0.8-10 mg/d folic acid supplements decrease serum concentrations of CRP.

Original title:
Effects of Folic Acid Supplementation on Inflammatory Markers: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials by Asbaghi O, Ashtary-Larky D, […], Naeini AA.

Link:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308638/

Additional information of El Mondo:
Find here more information/studies about review article/significant and folic acid.

 

Low vitamin D level increases asthma in children

Objectives:
The association between serum 25-hydroxyvitamin D 25(OH)D level (vitamin D level in blood) and asthma occurrence in children was controversial. Therefore, this review article has been conducted.

Does a low vitamin D level increase risk of asthma occurrence in children?

Study design:
This review article included 35 studies with 5,711 children with asthma and 21,561 children without asthma. Among them, 24 studies were included for analyzing the association between 25(OH)D level and asthma and 12 studies evaluated the treatment effect of vitamin D.

Results and conclusions:
The investigators found that the children with asthma had significant lower 25(OH)D level than children without asthma [21.7 ng/mL versus 26.5 ng/mL, SMD = -1.36, 95% CI = -2.40 to -0.32, p = 0.010].

The investigators found, besides, children with asthma treated with vitamin D supplement had a significantly lower recurrence rate of 65% than the placebo group [18.4% versus 35.9%, RR = 0.35, 95% CI = 0.35 to 0.79, p = 0.002].

The investigators concluded that children with asthma have a lower 25(OH)D level than healthy children. Vitamin D supplement could decrease the asthma recurrence rate in the follow-up years.

Original title:
Vitamin D and asthma occurrence in children: A systematic review and meta-analysis by Wang Q, Ying Q, [...], Chen J.

Link:
https://pubmed.ncbi.nlm.nih.gov/34366195/

Additional information of El Mondo:
Find here more information/studies about review article/significant and vitamin D.

Low vitamin D level increases acne

Objectives:
Vitamin D deficiency is frequently associated with several medical conditions. However, a comprehensive meta-analysis assessing the association between vitamin D level and acne is lacking. Therefore, this review article (meta-analysis) has been conducted.

Does a low vitamin D level (expressed as circulating 25(OH)D levels) increase risk of both acne and acne severity?

Study design:
This review article included 13 articles with a total of 1,362 acne patients and 1,081 healthy controls (persons without acne).

Results and conclusions:
The investigators found that the circulating 25(OH)D levels were significantly lower in patients with acne than in healthy controls [pooled MD = -9.02 ng/mL, 95% CI = -13.22 to -4.81, p 0.0001].

The investigators found that vitamin D deficiency was more prevalent in acne patients than in healthy controls [pooled OR = 2.97, 95% CI = 1.68 to 5.23, I2 = 72%].

The investigators found that vitamin D levels were negatively correlated with acne severity.

The investigators concluded that the vitamin D levels are low in acne patients. Also, there is evidence of an inverse association between vitamin D levels and acne severity. Therefore, vitamin D might be involved in the pathogenesis (the manner of development of a disease) of acne.

Original title:
Association between Vitamin D Level and Acne, and Correlation with Disease Severity: A Meta-Analysis by Hasamoh Y, Thadanipon K, […], Juntongjin P.

Link:
https://pubmed.ncbi.nlm.nih.gov/34348293/

Additional information of El Mondo:
Find here more information/studies about review article/significant, chronic diseases and vitamin D.

Selenium supplementation decreases hs-CRP level among patients with metabolic diseases

Objectives:
Selenium (Se) is a trace element having significant effects on human metabolism. Recent studies suggest that selenium supplementation have a pivotal effect on the inflammatory markers. Therefore, this review article has been conducted.

Does selenium supplementation reduce plasma inflammatory markers including C-reactive protein (CRP) and high-sensitivity C-reactive protein (hs-CRP) and nitric oxide (NO) as a stress oxidative index, among patients with metabolic diseases?

Study design:
This review article included 7 RCTs.

Results and conclusions:
The investigators found subgroup analysis of CRP type showed that selenium supplementation significantly decreased hs-CRP level [pooled SMD = -0.44, 95% CI = -0.67 to -0.21] among patients with metabolic diseases.

The investigators concluded that selenium supplementation decreases hs-CRP level among patients with metabolic diseases.

Original title:
The effects of dietary selenium supplementation on inflammatory markers among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials by Djalalinia S, Hasani M, […], Qorbani M.

Link:
https://pubmed.ncbi.nlm.nih.gov/34222098/

Additional information of El Mondo:
Find here more information/studies about review article/significant, chronic disease and selenium.

Dietary sodium restriction causally reduces blood pressure in patients with type 2 diabetes mellitus

Objectives:
Although current guidelines recommend reduction of salt intake in patients with diabetes, the benefits of reducing salt intake in people with type 2 diabetes mellitus (T2DM) lack clear evidence. Therefore, this review articles has been conducted.

Does dietary sodium restriction causally reduce blood pressure in patients with type 2 diabetes mellitus (T2DM)?

Study design:
This review article included 8 RCTs with 10 trials (7 cross-over and 3 parallel designs).
No publication bias was found from Begg's and Egger's tests.

Results and conclusions:
The investigators found compared with ordinary sodium intake, dietary sodium restriction significantly decreased 24-hour urine sodium level [WMD = -38.430 mmol/24h, 95% CI = -41.665 mmol/24h to -35.194 mmol/24h].

The investigators found dietary sodium restriction significantly lowered systolic blood pressure [WMD = -5.574 mm Hg, 95% CI = -8.314 to -2.834 mm Hg, I2 = 0.0%] and diastolic blood pressure [WMD = -1.675 mm Hg, 95% CI = -3.199 to -0.150 mm Hg, I2 = 0.0%].

The investigators concluded that dietary sodium restriction causally reduces systolic blood pressure and diastolic blood pressure in patients with type 2 diabetes mellitus (T2DM).

Original title:
Effect of dietary sodium restriction on blood pressure in type 2 diabetes: A meta-analysis of randomized controlled trials by Ren Y, Liqiang Qin L, […], Ma Y.

Link:
https://pubmed.ncbi.nlm.nih.gov/33838996/

Additional information of El Mondo:
Find more information/studies on sodium and diabetes right here.

Salt consists of sodium and chloride. So a dietary sodium restriction means a reduction in dietary salt intake.

A diet with dietary salt restriction is a diet with maximum 0.2 grams of salt per 100 kcal.

The easiest way to follow this diet is to choose only products/meals with maximum 0.2 grams of salt per 100 kcal. These products from the supermarket contain maximum 0.2 grams of salt per 100 kcal.

However, the most practical way to follow this diet is, all your daily consumed products/meals should contain on average maximum 0.2 grams of salt per 100 kcal.
To do this, use the 7-points nutritional profile app to see if your daily diet contains maximum 0.2 grams of salt per 100 kcal.

Daily 80g potato increase type 2 diabetes among Western populations

Objectives:
Evidence regarding associations between potato consumption and type 2 diabetes (T2D) and gestational diabetes mellitus (GDM) risks is accumulating. Therefore, this review article has been conducted.

Does a high potato intake increase type 2 diabetes and gestational diabetes mellitus (diabetes mellitus during pregnancy) risk?

Study design:
This review article included 19 studies (13 for type 2 diabetes and 6 for gestational diabetes mellitus) with a total of 21,357 type 2 diabetes cases among 323,475 participants and 1,516 gestational diabetes mellitus cases among 29,288 pregnancies.

Results and conclusions:
The investigators found meta-analysis showed a significantly increased risk of 19% [RR = 1.19, 95% CI = 1.06 to 1.34] for type 2 diabetes for total potato intakes among Western populations.

The investigators found meta-analysis showed a significantly increased risk of 8% [RR = 1.08, 95% CI = 1.00 to 1.16] for type 2 diabetes for baked/boiled/mashed potato intakes among Western populations.

The investigators found meta-analysis showed a significantly increased risk of 33% [RR = 1.33, 95% CI = 1.03 to 1.70] for type 2 diabetes for French fries/fried potato intakes among Western populations.

The investigators found dose-response meta-analysis demonstrated a significantly increased type 2 diabetes risk by 10% [95% CI = 1.07 to 1.14, p for trend 0.001], 2% [95% CI = 1.00 to 1.04, p for trend = 0.02] and 34% [95% CI = 1.24 to 1.46, p for trend 0.001] among Western populations for each 80 g/day (serving) increment in total potato, unfried potato and fried potato intakes, respectively.

The investigators found dose-response meta-analysis demonstrated a significantly increased gestational diabetes mellitus risk by 22% [95% CI = 1.06 to 1.42, p for trend 0.007] among Western populations for each 80 g/day (serving) increment in total potato intakes.

The investigators found dose-response meta-analysis demonstrated a significantly increased gestational diabetes mellitus risk by 26% [95% CI = 1.07 to 1.48, p for trend = 0.006] among Western populations for each 80 g/day (serving) increment in unfried potato intakes.

The investigators concluded that higher potato intake (at least 80g per day) is associated with higher type 2 diabetes risk among Western populations. The positive relationship presents a significant dose-response manner. Wisely controlled potato consumption may confer potential glucometabolic benefits.

Original title:
Dietary potato intake and risks of type 2 diabetes and gestational diabetes mellitus by Guo F, Zhang Q, [...], Ma L.

Link:
https://pubmed.ncbi.nlm.nih.gov/34130021/

Additional information of El Mondo:
Find more information/studies on potato intakes and diabetes right here.

NAC supplementation could improve lung function in patients with acute exacerbation of chronic obstructive pulmonary disease

Objectives:
Whether N-acetylcysteine (NAC) therapy can promote the improvement of clinical symptoms and lung function in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has not been verified by large-scale randomized controlled trials, only a few small sample studies. Therefore, this review article has been conducted.

Does n-acetylcysteine (NAC) supplementation improve clinical symptoms and lung function in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?

Study design:
This review article included 12 retrospective analyses and 3 randomized controlled trials (RCTs) with 1,605 patients.
The 15 included studies were small sample studies, with sample sizes ranging from 72 to 146.

9 studies had a Jadad score of 3-5 points and 6 studies had a Jadad score of 1-2 points.

Results and conclusions:
The investigators found the meta-analysis results of 10 studies (525 cases in the n-acetylcysteine group and 524 cases in the control group) showed that the forced expiratory volume in the first second (FEV1) of the n-acetylcysteine group was markedly higher than that of the control group; the mean difference was 30.63 [95% CI = 25.48 to 35.78, I2 = 92%] and the difference was statistically significant [z = 11.65 and p 0.0001].

The investigators found the meta-analysis results of 6 studies (347 cases in the n-acetylcysteine group and 350 cases in the control group) showed that forced expiratory volume in the first second/forced vital capacity (FEV1/FVC) of the n-acetylcysteine group was markedly higher than that of the control group; the mean difference was 30.42 [95% CI = 24.00 to 36.85, I2 = 93%] and the difference was statistically significant [z = 9.28 and p 0.0001].

The investigators found the meta-analysis results of 6 studies (323 cases in the n-acetylcysteine group and 322 cases in the control group) showed that the glutathione sulfur transferase (GSH-ST) activity of the n-acetylcysteine group was notably greater than that of the control group; the mean difference was 3.10 [95% CI = 1.38 to 4.82, I2 = 91%] and the difference was statistically significant [z = 3.63, p = 0.0004].

The investigators found the meta-analysis results of 4 studies (224 cases in the n-acetylcysteine group and 227 cases in the control group) showed that the ability of the n-acetylcysteine group to inhibit hydroxyl free radicals was higher than that of the control group; the mean difference was 77.52 [95% CI = 61.01 to 94.03, I2 = 44%] and the difference was statistically significant [z = 9.20 and p 0.0001]. 

The investigators found the meta-analysis results of 4 studies (224 cases in the n-acetylcysteine group and 227 cases in the control group) showed that the superoxide anion radical resistance ability of the n-acetylcysteine group was greater than the ability of the control group; the mean difference was 47.75 [95% CI = 36.26 to 59.25, I2 = 35%] and the difference was statistically significant [z = 8.14 and p 0.0001]. 

The investigators concluded n-acetylcysteine (NAC) supplementation could promote the symptom improvement rate of patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), improve lung function in FEV1 and FEV1/FVC and enhance the body’s antioxidant capacity. Could because the sample size of the literature included in this review article was small. The sample size should be expanded in future randomized controlled trials to verify these findings. All in all, the results of this review article can provide a reliable theoretical basis for the clinical treatment of AECOPD, so that patients can benefit from NAC treatment.

Original title:
Systematic review and meta-analysis of the efficacy of N-acetylcysteine in the treatment of acute exacerbation of chronic obstructive pulmonary disease by Jiang C, Zou J, [...], Yang Y.

Link:
https://apm.amegroups.com/article/view/72787/html

Additional information of El Mondo:
Find here more information/studies about review article/significant, COPD and n-acetylcysteine.

An acute exacerbation of chronic obstructive pulmonary disease is a sudden worsening of chronic obstructive pulmonary disease (COPD) symptoms including shortness of breath, quantity and color of phlegm that typically lasts for several days.
 

Zinc supplementation does not increase brain derived neurotrophic factor levels

Objectives:
Zinc in one of the most abundant trace minerals in human body which is involved in numerous biological pathways and has variety of roles in the nervous system. It has been assumed that zinc exerts its role in nervous system through increasing brain derived neurotrophic factor (BDNF) concentrations. Therefore, this review article has been conducted.

Does zinc supplementation increase brain derived neurotrophic factor (BDNF) levels?

Study design:
This review article included 5 studies with 238 participants. These studies enrolled subjects with premenstrual syndrome, diabetic retinopathy, major depression disorder, overweight/obese and obese with mild to moderate depressive disorders.

Funnel plot did not suggest publication bias.

Results and conclusions:
The investigators found zinc supplementation failed to increase blood brain derived neurotrophic factor concentrations with effect size of 0.30 [95% CI = -0.08 to 0.67, p = 0.119].

The investigators concluded zinc supplementation does not increase brain derived neurotrophic factor (BDNF) levels. However, the small number of included articles and significant heterogeneity between them can increase the risk of a false negative result; therefore, the results should be interpreted with caution.

Original title:
The effect of zinc supplementation on brain derived neurotrophic factor: A meta-analysis by Jafari F, Mohammadi H and Amani R.

Link:
https://pubmed.ncbi.nlm.nih.gov/33831797/

Additional information of El Mondo:
Find here more information/studies about review article/significant and zinc.

Brain Derived Neurotrophic Factor (BDNF) plays an important role in neuronal survival and growth, serves as a neurotransmitter modulator and participates in neuronal plasticity, which is essential for learning and memory.
Decreased levels of BDNF are associated with neurodegenerative diseases with neuronal loss, such as Parkinson's disease, Alzheimer's disease, multiple sclerosis and Huntington's disease.